131 related articles for article (PubMed ID: 7862694)
1. Effects of chronic treatment with triazolam on operant responding in rats.
Cohen C; Sanger DJ
Pharmacol Biochem Behav; 1994 Nov; 49(3):455-61. PubMed ID: 7862694
[TBL] [Abstract][Full Text] [Related]
2. Tolerance, cross-tolerance and dependence measured by operant responding in rats treated with triazolam via osmotic pumps.
Cohen C; Sanger DJ
Psychopharmacology (Berl); 1994 Jun; 115(1-2):86-94. PubMed ID: 7862917
[TBL] [Abstract][Full Text] [Related]
3. Effects of zolpidem, a new imidazopyridine hypnotic, on the acquisition of conditioned fear in mice. Comparison with triazolam and CL 218,872.
Sanger DJ; Joly D; Zivkovic B
Psychopharmacology (Berl); 1986; 90(2):207-10. PubMed ID: 2878460
[TBL] [Abstract][Full Text] [Related]
4. Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors.
Sanger DJ; Zivkovic B
Neuropharmacology; 1992 Jul; 31(7):693-700. PubMed ID: 1357576
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats.
Rowlett JK; Woolverton WL
J Pharmacol Exp Ther; 1997 Jan; 280(1):162-73. PubMed ID: 8996194
[TBL] [Abstract][Full Text] [Related]
6. The effects of benzodiazepine (triazolam), cyclopyrrolone (zopiclone) and imidazopyridine (zolpidem) hypnotics on the frequency of hippocampal theta activity and sleep structure in rats.
Yoshimoto M; Higuchi H; Kamata M; Yoshida K; Shimizu T; Hishikawa Y
Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):29-35. PubMed ID: 10082225
[TBL] [Abstract][Full Text] [Related]
7. Reversal of triazolam- and zolpidem-induced memory impairment by flumazenil.
Wesensten NJ; Balkin TJ; Davis HQ; Belenky GL
Psychopharmacology (Berl); 1995 Sep; 121(2):242-9. PubMed ID: 8545530
[TBL] [Abstract][Full Text] [Related]
8. The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic.
Sanger DJ; Zivkovic B
Psychopharmacology (Berl); 1986; 89(3):317-22. PubMed ID: 2873608
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the development of tolerance to the actions of zolpidem and midazolam.
Sanger DJ; Zivkovic B
Neuropharmacology; 1987 Oct; 26(10):1513-8. PubMed ID: 3683765
[TBL] [Abstract][Full Text] [Related]
10. Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal.
Griffiths RR; Sannerud CA; Ator NA; Brady JV
J Pharmacol Exp Ther; 1992 Mar; 260(3):1199-208. PubMed ID: 1312162
[TBL] [Abstract][Full Text] [Related]
11. Response-rate suppression in operant paradigm as predictor of soporific potency in rats and identification of three novel sedative-hypnotic neuroactive steroids.
Vanover KE; Edgar DM; Seidel WF; Hogenkamp DJ; Fick DB; Lan NC; Gee KW; Carter RB
J Pharmacol Exp Ther; 1999 Dec; 291(3):1317-23. PubMed ID: 10565857
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
[TBL] [Abstract][Full Text] [Related]
13. Effects of daytime administration of zolpidem versus triazolam on memory.
Wesensten NJ; Balkin TJ; Belenky GL
Eur J Clin Pharmacol; 1995; 48(2):115-22. PubMed ID: 7589024
[TBL] [Abstract][Full Text] [Related]
14. Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.
Rush CR; Baker RW; Wright K
Psychopharmacology (Berl); 1999 Jun; 144(3):220-33. PubMed ID: 10435388
[TBL] [Abstract][Full Text] [Related]
15. Different effects of L-type and T-type calcium channel blockers on the hypnotic potency of triazolam and zolpidem in rats.
Takahashi H; Yoshimoto M; Higuchi H; Shimizu T; Hishikawa Y
Eur Neuropsychopharmacol; 1999 Jun; 9(4):317-21. PubMed ID: 10422892
[TBL] [Abstract][Full Text] [Related]
16. Zolpidem, triazolam, and diazepam decrease distress vocalizations in mouse pups: differential antagonism by flumazenil and beta-Carboline-3-carboxylate-t-butyl ester (beta-CCt).
Rowlett JK; Tornatzky W; Cook JM; Ma C; Miczek KA
J Pharmacol Exp Ther; 2001 Apr; 297(1):247-53. PubMed ID: 11259551
[TBL] [Abstract][Full Text] [Related]
17. Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure.
Mintzer MZ; Frey JM; Griffiths RR
Behav Pharmacol; 1998 Nov; 9(7):545-59. PubMed ID: 9862080
[TBL] [Abstract][Full Text] [Related]
18. Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.
Rush CR; Griffiths RR
J Clin Psychopharmacol; 1996 Apr; 16(2):146-57. PubMed ID: 8690830
[TBL] [Abstract][Full Text] [Related]
19. Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers.
Mintzer MZ; Frey JM; Yingling JE; Griffiths RR
Behav Pharmacol; 1997 Nov; 8(6-7):561-74. PubMed ID: 9832970
[TBL] [Abstract][Full Text] [Related]
20. Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.
Griebel G; Perrault G; Sanger DJ
J Psychopharmacol; 1998; 12(4):356-65. PubMed ID: 10065909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
